No Data
Autobio Diagnostics' Chairman Raises Stake in Company for 21 Million Yuan
Autobio Diagnostics (603658.SH): The Chairman and actual controller, Miao Yongjun, has cumulatively completed a Shareholding of approximately 21 million yuan of the company's shares.
Gelonghui, December 12th丨Autobio Diagnostics (603658.SH) announced that as of December 12, 2024, the term of the shareholding plan implemented by Mr. Miao Yongjun, Chairman and actual controller, has expired. Mr. Miao Yongjun has cumulatively increased his shareholding in the company by 452,800 shares through the centralized bidding trading system of the Shanghai Stock Exchange, accounting for 0.0779% of the company's total share capital, with a cumulative investment amount of 21,021,355 yuan. This shareholding plan has been completed.
Autobio Diagnostics (603658.SH) and its subsidiaries will manage cash for idle funds not exceeding 2.39 billion yuan.
On December 11th, Gelonghui announced that Autobio Diagnostics (603658.SH) disclosed that to fully utilize the temporarily idle self-owned funds of the company and further improve the return on funds, while ensuring that normal production and Operation are not affected, the company and its subsidiaries will manage idle self-owned funds up to a maximum of 2.39 billion yuan for cash management, used for purchasing financial products with high safety, good liquidity, and controllable risks. Within the above limits, the funds can be used on a rolling basis within 12 months.
autobio diagnostics (603658.SH): Received the administrative supervision measures decision from Henan Securities Regulatory Bureau
On December 9th, Gelonghui reported that autobio diagnostics (603658.SH) announced that the company recently received the Administrative Supervision Measures Decision No. 100 (2024) issued by the Henan Regulatory Bureau of the China Securities Regulatory Commission (referred to as 'Henan Securities Regulatory Bureau'), 'Decision on Issuing a Warning Letter Measures to Zhengzhou Autobio Diagnostics Co., Ltd. and Related Responsible Persons.'
Autobio Diagnostics (603658.SH): has repurchased 1.60% of the shares.
Grain Note 2 December२२.Autobio Diagnostics (603658.SH) announced that as of November 30, 2024, the company has repurchased a total of 9,308,752 shares through centralized competitive trading, accounting for 1.60% of the company's total share capital. The highest price traded was 59.99 yuan/share, the lowest price was 37.91 yuan/share, and the total amount paid was 433,868,879.17 yuan (excluding transaction costs).
Autobio Diagnostics: Molecular sector is growing rapidly, subsidiary disputes may be resolved soon | Earnings Conference
① The secretary of the board of directors of autobio diagnostics stated at the earnings conference that the significant increase in R&D expenses led to a decline in Q3 net income attributable to the parent company; ② The chairman of autobio diagnostics, Miao Yongjun, informed investors that the molecular sector is expected to maintain high-speed growth, while the microbiology sector will achieve steady growth of 15%-20% each year.
Earnings Not Telling The Story For Autobio Diagnostics Co., Ltd. (SHSE:603658) After Shares Rise 26%
